Dauntless Investment Group LLC 13D and 13G filings for OKYO Pharma Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 4:19 pm Sale | 2025-12-31 | 13G | OKYO PHARMA LTD SHS USD OKYO | Dauntless Investment Group LLC | 471,523 1.200% | -1,950,525 (-80.53%) | Filing |
| 2025-11-14 12:50 pm Sale | 2025-09-30 | 13G | OKYO PHARMA LTD SHS USD OKYO | Dauntless Investment Group LLC | 2,422,048 6.300% | -313,732 (-11.47%) | Filing |
| 2025-08-05 3:22 pm Purchase | 2025-06-30 | 13G | OKYO PHARMA LTD SHS USD OKYO | Dauntless Investment Group LLC | 2,735,780 7.300% | 736,400 (+36.83%) | Filing |
| 2025-03-18 2:35 pm Purchase | 2025-03-12 | 13G | OKYO PHARMA LTD SHS USD OKYO | Dauntless Investment Group LLC | 1,999,380 5.900% | 1,999,380 (New Position) | Filing |